Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1952 2
1953 1
1955 1
1957 3
1958 1
1961 1
1964 1
1979 1
1980 3
1981 8
1982 21
1983 50
1984 59
1985 84
1986 102
1987 102
1988 120
1989 136
1990 218
1991 151
1992 144
1993 187
1994 141
1995 156
1996 177
1997 131
1998 135
1999 145
2000 119
2001 119
2002 119
2003 115
2004 110
2005 103
2006 137
2007 129
2008 110
2009 126
2010 95
2011 116
2012 133
2013 131
2014 121
2015 103
2016 99
2017 109
2018 115
2019 121
2020 113
2021 96
2022 134
2023 110
2024 40

Text availability

Article attribute

Article type

Publication date

Search Results

4,807 results

Results by year

Filters applied: . Clear all
Page 1
Nimodipine Reappraised: An Old Drug With a Future.
Carlson AP, Hänggi D, Macdonald RL, Shuttleworth CW. Carlson AP, et al. Curr Neuropharmacol. 2020;18(1):65-82. doi: 10.2174/1570159X17666190927113021. Curr Neuropharmacol. 2020. PMID: 31560289 Free PMC article. Review.
Nimodipine is a dihydropyridine calcium channel antagonist that blocks the flux of extracellular calcium through L-type, voltage-gated calcium channels. ...In addition, we will review pivotal trials using locally administered, sustained release nimodipine and discus …
Nimodipine is a dihydropyridine calcium channel antagonist that blocks the flux of extracellular calcium through L-type, voltage-gate …
Nimodipine in Clinical Practice: A Pharmacological Update.
Clough B, Tenii J, Wee C, Gunter E, Griffin T, Aiyagari V. Clough B, et al. J Neurosci Nurs. 2022 Feb 1;54(1):19-22. doi: 10.1097/JNN.0000000000000625. J Neurosci Nurs. 2022. PMID: 34775392 Review.
Nimodipine remains the only US Food and Drug Administration-approved medication for aSAH. CONTENT: Nimodipine has been prescribed for patients with aSAH; however, little is known about factors to consider regarding dosing or patient-specific variables that may affec …
Nimodipine remains the only US Food and Drug Administration-approved medication for aSAH. CONTENT: Nimodipine has been prescri …
Nimodipine.
Das JM, Zito PM. Das JM, et al. 2024 May 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2024 May 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30521291 Free Books & Documents.
Nimodipine is a second-generation 1,4-dihydropyridine calcium channel blocker that was originally approved by the FDA to manage hypertension. ...Nimodipine is available in various formulations, including oral tablets, solutions, and intravenous infusions. ...
Nimodipine is a second-generation 1,4-dihydropyridine calcium channel blocker that was originally approved by the FDA to manage hyper …
Nimodipine for the treatment of otolaryngic indications.
Sin JH, Shafeeq H, Levy ZD. Sin JH, et al. Am J Health Syst Pharm. 2018 Sep 15;75(18):1369-1377. doi: 10.2146/ajhp170677. Am J Health Syst Pharm. 2018. PMID: 30190294 Review.
Several studies of Meniere's disease and/or peripheral vertigo have reported improved symptom control with nimodipine. For vocal fold paralysis associated with recurrent laryngeal nerve (RLN) injury, nimodipine may increase the recovery rate based on the results of …
Several studies of Meniere's disease and/or peripheral vertigo have reported improved symptom control with nimodipine. For vocal fold …
Nimodipine improves vocal fold and facial motion recovery after injury: A systematic review and meta-analysis.
Lin RJ, Klein-Fedyshin M, Rosen CA. Lin RJ, et al. Laryngoscope. 2019 Apr;129(4):943-951. doi: 10.1002/lary.27530. Epub 2018 Nov 19. Laryngoscope. 2019. PMID: 30450691
INTRODUCTION: Nimodipine is a calcium channel blocker that has been used to treat hypertension and vasospasm. ...OBJECTIVES: To conduct a systematic review of the usage of nimodipine in cranial nerve injury and to perform a meta-analysis to estimate the efficacy of …
INTRODUCTION: Nimodipine is a calcium channel blocker that has been used to treat hypertension and vasospasm. ...OBJECTIVES: To condu …
Nimodipine Reduces Microvasospasms After Experimental Subarachnoid Hemorrhage.
Schwarting J, Harapan BN, Lin X, Plesnila N, Terpolilli NA. Schwarting J, et al. Stroke. 2023 Oct;54(10):2666-2670. doi: 10.1161/STROKEAHA.123.043976. Epub 2023 Sep 7. Stroke. 2023. PMID: 37675614
BACKGROUND: The only established pharmacological treatment option improving outcomes for patients suffering from subarachnoid hemorrhage (SAH) is the L-type-calcium channel inhibitor nimodipine. However, the exact mechanisms of action of nimodipine conferring neurop …
BACKGROUND: The only established pharmacological treatment option improving outcomes for patients suffering from subarachnoid hemorrhage (SA …
Nimodipine in subarachnoid hemorrhage.
DiPalma JR. DiPalma JR. Am Fam Physician. 1989 Dec;40(6):143-5. Am Fam Physician. 1989. PMID: 2686374 Review.
Nimodipine has recently been approved for the treatment of cerebral ischemia caused by subarachnoid hemorrhage. Chemically, nimodipine is in the same group of calcium channel blockers as nifedipine and nicardipine. ...
Nimodipine has recently been approved for the treatment of cerebral ischemia caused by subarachnoid hemorrhage. Chemically, nimodi …
Nimodipine.
Whitfield PC, Pickard JD. Whitfield PC, et al. Br J Hosp Med. 1994 Nov 16-Dec 13;52(10):539-40. Br J Hosp Med. 1994. PMID: 7858806
Nimodipine is a lipophilic dihydropyridine calcium antagonist which is used to reduce the incidence and severity of delayed cerebral ischaemia in patients with subarachnoid haemorrhage. ...
Nimodipine is a lipophilic dihydropyridine calcium antagonist which is used to reduce the incidence and severity of delayed cerebral …
Nimodipine. Potential for drug-drug interactions in the elderly.
Mück W, Ahr G, Kuhlmann J. Mück W, et al. Drugs Aging. 1995 Mar;6(3):229-42. doi: 10.2165/00002512-199506030-00006. Drugs Aging. 1995. PMID: 7620235 Review.
Nimodipine is indicated for a variety of conditions in elderly patients. ...Therefore concomitant use of these agents with oral nimodipine is not recommended. In contrast, epileptic patients treated with nimodipine and valproic acid (sodium valproate) showed …
Nimodipine is indicated for a variety of conditions in elderly patients. ...Therefore concomitant use of these agents with oral ni …
4,807 results